Table 2 Target items in cognitive impairment and T2DM management

HbA_1c (%)

7.2 (6.3, 8.2)

7.1 (6.4, 8.1)

-0.019

0.985

HbA_1c ≥ 7.0%, n (%)

110/191 (57.59%)

127/239 (53.14%)

0.851

0.356

HbA_1c ≥ 7.5%, n (%)

84/191 (43.98%)

95/239 (39.75%)

0.782

0.377

HbA_1c ≥ 8.0%, n (%)

56/191 (29.32%)

68/239 (28.45%)

0.039

0.844

Duration of T2DM (y)

6 (2, 11)

6 (1, 11)

-0.268

0.788

FBG (mmol/L)

8.4 (6.9, 10.7)

8.5 (7.0, 10.7)

0.465

0.642

FBG ≥ 7.0, n (%)

130/175 (74.29%)

189/243 (77.78%)

0.686

0.407

2-h PBG (mmol/L)

11.2 (9.6, 13.8)

11.7 (9.5, 14.4)

1.042

0.297

2-h PBG ≥ 10.0, n (%)

132/183 (72.13%)

167/238 (70.17%)

0.194

0.660

Admisson glucose (mmol/L)

9.5 (7.4, 13.2)

10.2 (7.2, 14.2)

0.513

0.608

SBP (mmHg)

138 ± 19

139 ± 20

0.195

0.649

DBP (mmHg)

80 (71, 88)

79 (71, 85)

-1.248

0.212

Total Cholesterol (mmol/L)

3.89 ± 0.91

3.86 ± 1.03

2.632

0.730

Triglyceride (mmol/L)

1.36 (1.03, 1.99)

1.39 (1.01, 1.91)

-0.022

0.983

HDL-C (mmol/L)

1.02 (0.86, 1.23)

1.00 (0.89, 1.19)

-0.384

0.701

LDL-C (mmol/L)

2.35 (1.71, 2.83)

2.22 (1.59, 2.79)

-0.754

0.451

Apo-A1 (g/L)

1.08 (0.96, 1.25)

1.06 (0.93, 1.21)

-1.181

0.238

Apo-B (g/L)

0.73 (0.59, 0.85)

0.71 (0.56, 0.88)

-0.879

0.380

BMI (kg/m²)

24.4 (23.1, 26.4)

24.5 (22.9, 26.6)

0.006

0.996

BMI stratification

3.336

0.503

Severely underweight, n (%)

0/190 (0)

1/235 (0.43%)

Underweight, n (%)

2/190 (1.05%)

1/235 (0.43%)

Normal weight, n (%)

45/190 (23.68%)

61/235 (25.95%)

Overweight, n (%)

66/190 (34.74%)

67/235 (28.51%)

Obesity, n (%)

77/190 (40.53%)

105/235 (44.68%)